Manifestation of Pig-a mutant bone marrow erythroids and peripheral blood erythrocytes in mice treated with N-ethyl-N-nitrosourea: direct sequencing of Pig-a cDNA from bone marrow cells negative for GPI-anchored protein expression.

Our previous rat studies indicate that the endogenous Pig-a gene is a promising reporter of in vivo mutation and potentially useful as the basis for an in vivo genotoxicity assay. The function of the Pig-a protein in the synthesis of glycosylphosphatidyl inositol (GPI) anchors is conserved in variety of eukaryotic cells, including human and rodent cells, which implies that Pig-a mutants can be measured in a similar manner in different mammalian species. In the present study, we developed a flow cytometric Pig-a assay for rapidly measuring gene mutation in the mouse. An antibody to TER-119, a specific cell-surface marker of murine erythroid lineage, was used to identify erythrocytes in peripheral blood (PB) and erythroids in bone marrow (BM). An antibody to CD24, a GPI-anchored protein, was used to identify Pig-a mutants as CD24-negative cells. CD-1 mice were administered a single dose of 100mg/kgN-ethyl-N-nitrosourea (ENU), and PB and BM were collected at 1, 2, and 4 weeks after dosing. While the Pig-a mutant frequency (MF) in PB was increased moderately at 2 and 4 weeks after ENU dosing, the Pig-a MF in BM was strongly increased starting at 1 week after the dosing, with the elevated MF persisting for at least 4 weeks after the dosing. We also used flow cytometric sorting to isolate CD24-negative erythroids from the BM of ENU-treated mice. cDNA sequencing indicated that these cells have mutations in the Pig-a gene, with base-pair substitutions typical of ENU-induced mutation spectra. The results indicate that the Pig-a mutation assay can be adapted for measuring mutation in BM erythroids and PB of mice. Taken together, the data suggest that Pig-a mutants are fixed in the BM, where they further proliferate and differentiate; erythrocytes derived from these BM Pig-a mutants transit from the BM and accumulate in PB.

[1]  R. Heflich,et al.  Accumulation and persistence of Pig-A mutant peripheral red blood cells following treatment of rats with single and split doses of N-ethyl-N-nitrosourea. , 2009, Mutation research.

[2]  Y. Katsuura,et al.  Development of an in vivo gene mutation assay using the endogenous Pig‐A gene: I. Flow cytometric detection of CD59‐negative peripheral red blood cells and CD48‐negative spleen T‐cells from the rat , 2008, Environmental and molecular mutagenesis.

[3]  I. Weissman,et al.  The monoclonal antibody TER‐119 recognizes a molecule associated with glycophorin A and specifically marks the late stages of murine erythroid lineage , 2000, British journal of haematology.

[4]  Lucio Luzzatto,et al.  The use of PIG-A as a sentinel gene for the study of the somatic mutation rate and of mutagenic agents in vivo. , 2010, Mutation research.

[5]  J. Bemis,et al.  In vivo mutation assay based on the endogenous Pig‐a locus , 2008, Environmental and molecular mutagenesis.

[6]  T. Skopek,et al.  Frequency and spectrum of ethylnitrosourea-induced mutation at the hprt and lacI loci in splenic lymphocytes of exposed lacI transgenic mice. , 1996, Cancer research.

[7]  P. Pandolfi,et al.  Fes-Cre Targets Phosphatidylinositol Glycan Class a (Piga) Inactivation to Hematopoietic Stem Cells in the Bone Marrow , 2001, The Journal of experimental medicine.

[8]  A. Yoshitake,et al.  Ethylnitrosourea-induced mutation and molecular analysis of transgenic mice containing the gpt shuttle vector. , 1999, Mutation research.

[9]  J. Bemis,et al.  Erythrocyte-based Pig-a gene mutation assay: demonstration of cross-species potential. , 2008, Mutation research.

[10]  T. Skopek,et al.  Mutational spectrum at the Hprt locus in splenic T cells of B6C3F1 mice exposed to N-ethyl-N-nitrosourea. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[11]  R. Mittelstaedt,et al.  Analysis of in vivo mutation induced by N‐ethyl‐N‐nitrosourea in the hprt gene of rat lymphocytes , 1995, Environmental and molecular mutagenesis.

[12]  S. Dertinger,et al.  The in vivo pig‐a gene mutation assay, a potential tool for regulatory safety assessment , 2010, Environmental and molecular mutagenesis.

[13]  Ollivier Hyrien,et al.  Pig-a mutation: kinetics in rat erythrocytes following exposure to five prototypical mutagens. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[14]  I. Lemischka,et al.  Clonal and systemic analysis of long-term hematopoiesis in the mouse. , 1990, Genes & development.

[15]  A. Tates,et al.  Detection of point mutations in T lymphocytes. , 1995, Clinical Chemistry.

[16]  M. Bishop,et al.  Flow cytometric detection of Pig‐A mutant red blood cells using an erythroid‐specific antibody: Application of the method for evaluating the in vivo genotoxicity of methylphenidate in adolescent rats , 2009, Environmental and molecular mutagenesis.

[17]  R. Mittelstaedt,et al.  Development of an in vivo gene mutation assay using the endogenous Pig‐A gene: II. Selection of Pig‐A mutant rat spleen T‐cells with proaerolysin and sequencing Pig‐A cDNA from the mutants , 2008, Environmental and molecular mutagenesis.